ClinVar Miner

Submissions for variant NM_000138.4(FBN1):c.1888A>T (p.Asn630Tyr) (rs1555399821)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000590583 SCV000695471 likely pathogenic Marfan syndrome 2017-12-12 criteria provided, single submitter clinical testing Variant summary: The FBN1 c.1888A>T (p.Asn630Tyr) variant involves the alteration of a conserved nucleotide that is located within one of the EGF-like calcium-binding domains (InterPro). 4/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). This variant is absent in 246208 control chromosomes. To our knowledge, the variant has not been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. However, variants involving the same codon (such as p.Asn630Ile and p.Asn630Lys) have been identified in affected individuals and are classified as pathogenic by another clinical lab (via ClinVar), and other surrounding variants (such as p.G626R, p.R627C, p.C628Y, and p.G633S) have also been reported in MFS patients, suggesting functional importance of this codon and nearby region. In addition, in an internal tested sample from a MFS patient, this variant has been confirmed as a de novo, further supporting a pathogenic outcome. Taken together, this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.